IDH1 and glioblastoma: Given the strong associations between IDH1 status and NCF, but also between IDH1 status and overall survival in patients with AA and GBM, baseline neurocognitive status would add in the future—along with other factors—a prognostic tool which, in turn, could assist physicians in selecting the best treatment plan.